A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
Clinical trial NCT06824051 · COMPLETED
Trial details
- NCT number
- NCT06824051
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-17
- Primary completion
- 2026-01-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.